Also check out
"Advancing continuous subcutaneous insulin infusion in vivo:New insights into tissue challenges" by Ulrike Klueh and her lab in J. Biomed Mater Research, 2020, p 1. I don't know if you can get it for free but her findings are the same pretty much the same. Her conclusions are " As sterile diluent was capable of inducing inflammation even in the absence of insulin, methods designed to reduce or neutralize these phenolic compounds' effects could extend device lifespan as well."
Now we just have to figure out how to do it.
BVA
"Advancing continuous subcutaneous insulin infusion in vivo:New insights into tissue challenges" by Ulrike Klueh and her lab in J. Biomed Mater Research, 2020, p 1. I don't know if you can get it for free but her findings are the same pretty much the same. Her conclusions are " As sterile diluent was capable of inducing inflammation even in the absence of insulin, methods designed to reduce or neutralize these phenolic compounds' effects could extend device lifespan as well."
Now we just have to figure out how to do it.
BVA